Advertisement
Letter to the Editor| Volume 86, ISSUE 1, P66-117, January 2023

Download started.

Ok

Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan

  • Jia-Arng Lee
    Affiliations
    Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for articles by this author
  • Shin-Hei Du
    Affiliations
    Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for articles by this author
  • Tai-fen Lee
    Affiliations
    Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for articles by this author
  • Yu-Shan Huang
    Affiliations
    Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for articles by this author
  • Chun-Hsing Liao
    Affiliations
    Colleague of Medicine, National Yang-Ming University, Taipei, Taiwan

    Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan
    Search for articles by this author
  • Yu-Tsung Huang
    Correspondence
    Corresponding author at: Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
    Affiliations
    Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

    Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan
    Search for articles by this author
  • Po-Ren Hsueh
    Correspondence
    Corresponding author at: Departments of Laboratory Medicine and Internal Medicine, China Medical University Hospital, School of Medicine, China Medical University, Taichung, Taiwan.
    Affiliations
    Departments of Laboratory Medicine and Internal Medicine, School of Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan

    Ph.D Program for Aging, College of Medicine, China Medical University, Taichung, Taiwan
    Search for articles by this author
Published:October 15, 2022DOI:https://doi.org/10.1016/j.jinf.2022.10.003
Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan
Previous ArticleLow serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation
Next ArticleEfficacy and safety of Paxlovid for COVID-19:a meta-analysis
      We read with great interest the article by Zha et al. describing a nationwide survey on the management of infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) in critically ill patients of tertiary hospitals in China.
      • Zha L.
      • Li S.
      • Ren Z.
      • Li X.
      • Zhang D.
      • Zou Y.
      • et al.
      Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a nationwide survey of tertiary hospitals in mainland China.
      J Infect. 2022; 84: e108-e110
      In this study, only 16% of the participating hospitals offered ceftazidime-avibactam (CZA) for treating carbapenem-resistant K. pneumoniae infections. The authors recommended that routine detection of carbapenemases and in vitro susceptibility for CZA among all CRKP isolates are necessary, as a nationwide survey in China has demonstrated an 11.1% of CRKP isolates resistant to this agent.
      • Zha L.
      • Li S.
      • Ren Z.
      • Li X.
      • Zhang D.
      • Zou Y.
      • et al.
      Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a nationwide survey of tertiary hospitals in mainland China.
      J Infect. 2022; 84: e108-e110
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Zha L.
        • Li S.
        • Ren Z.
        • Li X.
        • Zhang D.
        • Zou Y.
        • et al.
        Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a nationwide survey of tertiary hospitals in mainland China.
        J Infect. 2022; 84: e108-e110
        View in Article
        • Boyd S.E.
        • Livermore D.M.
        • Hooper D.C.
        • Hope WW.
        Metallo-beta-lactamases: structure, function, epidemiology, treatment options, and the development pipeline.
        Antimicrob Agents Chemother. 2020; 64 (e00397-20)
        View in Article
        • Huang Y.T.
        • Kuo Y.W.
        • Teng L.J.
        • Liao C.H.
        • Hsueh PR.
        Comparison of E test and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam.
        J Global Antimicrob Resist. 2021; 26: 301-307
        View in Article
        • Liao C.H.
        • Huang Y.T.
        • Hsueh PR.
        Multicenter surveillance of capsular serotypes, virulence genes, and antimicrobial susceptibilities of Klebsiella pneumoniae causing bacteremia in Taiwan, 2017–2019.
        Front Microbiol. 2022; 13783523
        View in Article
        • Wang C.H.
        • Ma L.
        • Huang L.Y.
        • Yeh K.M.
        • Lin J.C.
        • Siu L.K.
        • et al.
        Molecular epidemiology and resistance patterns of blaOXA-48 Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan.
        J Microbiol Immunol Infect. 2021; 54: 665-672
        View in Article
        • Coppi M.
        • Di Pilato V.
        • Monaco F.
        • Giani T.
        • Conaldi P.G.
        • Rossolini GM.
        Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae.
        AntimicrobAgents Chemother. 2020; 64: e01816-e01819
        View in Article
        • Huang Y.S.
        • Tsai W.C.
        • Li J.J.
        • Chen P.Y.
        • Wang J.T.
        • Chen Y.T.
        • et al.
        Increasing New Delhi metallo-beta-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018.
        Sci Rep. 2021; 11: 2609
        View in Article
        • Nordmann P.
        • Poirel L.
        Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria.
        Clin Infect Dis. 2019; 69 (Suppl): S521-S5S8
        View in Article
        • Huang Y.T.
        • Kuo Y.W.
        • Lee N.Y.
        • Tien N.
        • Liao C.H.
        • Teng L.J.
        • et al.
        Evaluating NG-Test CARBA 5 multiplex immunochromatographic and Cepheid Xpert CARBA-R assays among carbapenem-resistant Enterobacterales isolates associated with bloodstream infection.
        Microbiol Spectr. 2022; 10 (e01728-21)
        View in Article
        • Chen H.Y.
        • Jean S.S.
        • Lee Y.L.
        • Lu M.C.
        • Ko W.C.
        • Liu P.Y.
        • et al.
        Carbapenem-resistant Enterobacterales in long-term care facilities: a global and narrative review.
        Front Cell Infect Microbiol. 2021; 11601968
        View in Article

      Article info

      Publication history

      Published online: October 15, 2022
      Accepted: October 2, 2022

      Identification

      DOI: https://doi.org/10.1016/j.jinf.2022.10.003

      Copyright

      © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX